023410 — EUGENE Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩256bn
- KR₩1tn
- KR₩1tn
- 13
- 83
- 80
- 65
Annual cashflow statement for EUGENE, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 49,895 | 78,253 | 31,132 | 69,312 | -100,746 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -129,561 | -123,992 | 34,077 | 26,944 | 174,549 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 120,040 | 129,281 | -71,882 | -43,243 | -25,655 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 65,387 | 110,502 | 19,438 | 82,548 | 76,774 |
| Capital Expenditures | -32,610 | -23,667 | -53,744 | -56,290 | -38,167 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -17,649 | -211,231 | 65,534 | -59,941 | -330,271 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -50,259 | -234,898 | 11,789 | -116,231 | -368,439 |
| Financing Cash Flow Items | -20,579 | -26,853 | -30,410 | -28,009 | -86,870 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6,188 | 88,792 | -55,560 | 123,328 | 225,304 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 21,096 | -35,585 | -24,259 | 89,598 | -65,758 |